Selected research
Industry Research
Life Sciences and Healthcare Regulatory Services Industry Research Report 2026
Market perspective
The global Life Sciences and Healthcare Regulatory Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Life Sciences and Healthcare Regulatory Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Life Sciences and Healthcare Regulatory Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Life Sciences and Healthcare Regulatory Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Life Sciences and Healthcare Regulatory Services include Arnold & Porter, Baker McKenzie, Bird & Bird, Celegence, Clarivate, Cooley, Fenwick, IQVIA and Kirkland & Ellis LLP, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Life Sciences and Healthcare Regulatory Services market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Life Sciences and Healthcare Regulatory Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Life Sciences and Healthcare Regulatory Services Market by Company
Arnold & Porter
Baker McKenzie
Bird & Bird
Celegence
Clarivate
Cooley
Fenwick
IQVIA
Kirkland & Ellis LLP
Larson Maddox
Latham & Watkins LLP
Norton Rose Fulbright
Paul Hastings LLP
ProductLife Group
PwC
Ropes & Gray LLP
Sidley Austin
Simmons & Simmons
Voisin Consulting Life Sciences
Life Sciences and Healthcare Regulatory Services Segment by Type
Regulatory Submission and Strategy Service
Quality and Compliance Service
Pharmacovigilance and Risk Management Service
Others
Life Sciences and Healthcare Regulatory Services Segment by Application
Pharmaceutical Industry
Medical Device Industry
Biotechnology Industry
Other
Life Sciences and Healthcare Regulatory Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Life Sciences and Healthcare Regulatory Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Life Sciences and Healthcare Regulatory Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Life Sciences and Healthcare Regulatory Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Life Sciences and Healthcare Regulatory Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Life Sciences and Healthcare Regulatory Services Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Life Sciences and Healthcare Regulatory Services Revenue Market Share by Type (2021-2026)
Table 7. Global Life Sciences and Healthcare Regulatory Services Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Life Sciences and Healthcare Regulatory Services Revenue Market Share by Type (2027-2032)
Table 9. Global Life Sciences and Healthcare Regulatory Services Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Life Sciences and Healthcare Regulatory Services Revenue Market Share by Application (2021-2026)
Table 11. Global Life Sciences and Healthcare Regulatory Services Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Life Sciences and Healthcare Regulatory Services Revenue Market Share by Application (2027-2032)
Table 13. Global Life Sciences and Healthcare Regulatory Services Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Life Sciences and Healthcare Regulatory Services Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Life Sciences and Healthcare Regulatory Services Market Share by Region (2021-2026)
Table 16. Global Life Sciences and Healthcare Regulatory Services Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Life Sciences and Healthcare Regulatory Services Market Share by Region (2027-2032)
Table 18. Life Sciences and Healthcare Regulatory Services Industry Trends
Table 19. Life Sciences and Healthcare Regulatory Services Industry Drivers
Table 20. Life Sciences and Healthcare Regulatory Services Industry Opportunities and Challenges
Table 21. Life Sciences and Healthcare Regulatory Services Market Restraints
Table 22. Global Top Life Sciences and Healthcare Regulatory Services Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Life Sciences and Healthcare Regulatory Services Revenue Market Share by Players (2021-2026)
Table 24. Global Life Sciences and Healthcare Regulatory Services Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Life Sciences and Healthcare Regulatory Services, Headquarters and Area Served
Table 26. Global Life Sciences and Healthcare Regulatory Services Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Life Sciences and Healthcare Regulatory Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Life Sciences and Healthcare Regulatory Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Life Sciences and Healthcare Regulatory Services Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Life Sciences and Healthcare Regulatory Services Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Life Sciences and Healthcare Regulatory Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Life Sciences and Healthcare Regulatory Services Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Life Sciences and Healthcare Regulatory Services Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Life Sciences and Healthcare Regulatory Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Life Sciences and Healthcare Regulatory Services Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Life Sciences and Healthcare Regulatory Services Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Life Sciences and Healthcare Regulatory Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Life Sciences and Healthcare Regulatory Services Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Life Sciences and Healthcare Regulatory Services Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Life Sciences and Healthcare Regulatory Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Life Sciences and Healthcare Regulatory Services Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Life Sciences and Healthcare Regulatory Services Market Size by Country (2027-2032) & (US$ Million)
Table 45. Arnold & Porter Company Information
Table 46. Arnold & Porter Business Overview
Table 47. Arnold & Porter Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 48. Arnold & Porter Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 49. Arnold & Porter Recent Developments
Table 50. Baker McKenzie Company Information
Table 51. Baker McKenzie Business Overview
Table 52. Baker McKenzie Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 53. Baker McKenzie Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 54. Baker McKenzie Recent Developments
Table 55. Bird & Bird Company Information
Table 56. Bird & Bird Business Overview
Table 57. Bird & Bird Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 58. Bird & Bird Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 59. Bird & Bird Recent Developments
Table 60. Celegence Company Information
Table 61. Celegence Business Overview
Table 62. Celegence Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 63. Celegence Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 64. Celegence Recent Developments
Table 65. Clarivate Company Information
Table 66. Clarivate Business Overview
Table 67. Clarivate Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 68. Clarivate Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 69. Clarivate Recent Developments
Table 70. Cooley Company Information
Table 71. Cooley Business Overview
Table 72. Cooley Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 73. Cooley Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 74. Cooley Recent Developments
Table 75. Fenwick Company Information
Table 76. Fenwick Business Overview
Table 77. Fenwick Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 78. Fenwick Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 79. Fenwick Recent Developments
Table 80. IQVIA Company Information
Table 81. IQVIA Business Overview
Table 82. IQVIA Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 83. IQVIA Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 84. IQVIA Recent Developments
Table 85. Kirkland & Ellis LLP Company Information
Table 86. Kirkland & Ellis LLP Business Overview
Table 87. Kirkland & Ellis LLP Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 88. Kirkland & Ellis LLP Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 89. Kirkland & Ellis LLP Recent Developments
Table 90. Larson Maddox Company Information
Table 91. Larson Maddox Business Overview
Table 92. Larson Maddox Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 93. Larson Maddox Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 94. Larson Maddox Recent Developments
Table 95. Latham & Watkins LLP Company Information
Table 96. Latham & Watkins LLP Business Overview
Table 97. Latham & Watkins LLP Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 98. Latham & Watkins LLP Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 99. Latham & Watkins LLP Recent Developments
Table 100. Norton Rose Fulbright Company Information
Table 101. Norton Rose Fulbright Business Overview
Table 102. Norton Rose Fulbright Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 103. Norton Rose Fulbright Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 104. Norton Rose Fulbright Recent Developments
Table 105. Paul Hastings LLP Company Information
Table 106. Paul Hastings LLP Business Overview
Table 107. Paul Hastings LLP Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 108. Paul Hastings LLP Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 109. Paul Hastings LLP Recent Developments
Table 110. ProductLife Group Company Information
Table 111. ProductLife Group Business Overview
Table 112. ProductLife Group Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 113. ProductLife Group Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 114. ProductLife Group Recent Developments
Table 115. PwC Company Information
Table 116. PwC Business Overview
Table 117. PwC Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 118. PwC Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 119. PwC Recent Developments
Table 120. Ropes & Gray LLP Company Information
Table 121. Ropes & Gray LLP Business Overview
Table 122. Ropes & Gray LLP Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 123. Ropes & Gray LLP Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 124. Ropes & Gray LLP Recent Developments
Table 125. Sidley Austin Company Information
Table 126. Sidley Austin Business Overview
Table 127. Sidley Austin Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 128. Sidley Austin Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 129. Sidley Austin Recent Developments
Table 130. Simmons & Simmons Company Information
Table 131. Simmons & Simmons Business Overview
Table 132. Simmons & Simmons Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 133. Simmons & Simmons Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 134. Simmons & Simmons Recent Developments
Table 135. Voisin Consulting Life Sciences Company Information
Table 136. Voisin Consulting Life Sciences Business Overview
Table 137. Voisin Consulting Life Sciences Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026) & (US$ Million)
Table 138. Voisin Consulting Life Sciences Life Sciences and Healthcare Regulatory Services Product Portfolio
Table 139. Voisin Consulting Life Sciences Recent Developments
Table 140. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Life Sciences and Healthcare Regulatory Services Product Image
Figure 5. Global Life Sciences and Healthcare Regulatory Services Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Life Sciences and Healthcare Regulatory Services Market Share by Type: 2025 VS 2032
Figure 7. Regulatory Submission and Strategy Service Product
Figure 8. Quality and Compliance Service Product
Figure 9. Pharmacovigilance and Risk Management Service Product
Figure 10. Others Product
Figure 11. Global Life Sciences and Healthcare Regulatory Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global Life Sciences and Healthcare Regulatory Services Market Share by Application: 2025 VS 2032
Figure 13. Pharmaceutical Industry Product
Figure 14. Medical Device Industry Product
Figure 15. Biotechnology Industry Product
Figure 16. Other Product
Figure 17. Global Life Sciences and Healthcare Regulatory Services Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 18. Global Life Sciences and Healthcare Regulatory Services Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 19. Global Life Sciences and Healthcare Regulatory Services Market Share by Region: 2025 VS 2032
Figure 20. Global Life Sciences and Healthcare Regulatory Services Market Share by Players in 2025
Figure 21. Global Life Sciences and Healthcare Regulatory Services Manufacturers Established Date
Figure 22. Global Top 5 and 10 Life Sciences and Healthcare Regulatory Services Players Market Share by Revenue in 2025
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 24. North America Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. North America Life Sciences and Healthcare Regulatory Services Market Share by Country (2021-2032)
Figure 26. United States Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Canada Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Mexico Life Sciences and Healthcare Regulatory Services Market Share by Country (2021-2032)
Figure 29. Europe Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. Europe Life Sciences and Healthcare Regulatory Services Market Share by Country (2021-2032)
Figure 31. Germany Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. France Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. U.K. Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Italy Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Spain Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Russia Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Netherlands Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Nordic Countries Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Asia-Pacific Life Sciences and Healthcare Regulatory Services Market Share by Country (2021-2032)
Figure 41. China Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. Japan Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. South Korea Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. India Life Sciences and Healthcare Regulatory Services Market Share by Country (2021-2032)
Figure 46. Australia Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. China Taiwan Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. Southeast Asia Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. South America Life Sciences and Healthcare Regulatory Services Market Share by Country (2021-2032)
Figure 51. Brazil Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Argentina Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Chile Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Colombia Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Peru Life Sciences and Healthcare Regulatory Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Arnold & Porter Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 57. Baker McKenzie Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 58. Bird & Bird Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 59. Celegence Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 60. Clarivate Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 61. Cooley Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 62. Fenwick Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 63. IQVIA Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 64. Kirkland & Ellis LLP Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 65. Larson Maddox Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 66. Latham & Watkins LLP Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 67. Norton Rose Fulbright Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 68. Paul Hastings LLP Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 69. ProductLife Group Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 70. PwC Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 71. Ropes & Gray LLP Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 72. Sidley Austin Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 73. Simmons & Simmons Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Figure 74. Voisin Consulting Life Sciences Revenue Growth Rate in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
Scope & coverage.
Types
- Regulatory Submission and Strategy Service
- Quality and Compliance Service
- Pharmacovigilance and Risk Management Service
- Others
Applications
- Pharmaceutical Industry
- Medical Device Industry
- Biotechnology Industry
- Other
Companies covered
- Arnold & Porter
- Baker McKenzie
- Bird & Bird
- Celegence
- Clarivate
- Cooley
- Fenwick
- IQVIA
- Kirkland & Ellis LLP
- Larson Maddox
- Latham & Watkins LLP
- Norton Rose Fulbright
- Paul Hastings LLP
- ProductLife Group
- PwC
- Ropes & Gray LLP
- Sidley Austin
- Simmons & Simmons
- Voisin Consulting Life Sciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Life Sciences and Healthcare Regulatory Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Regulatory Submission and Strategy Service
- 2.2.3 Quality and Compliance Service
- 2.2.4 Pharmacovigilance and Risk Management Service
- 2.2.5 Others
- 2.3 Life Sciences and Healthcare Regulatory Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Industry
- 2.3.3 Medical Device Industry
- 2.3.4 Biotechnology Industry
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Life Sciences and Healthcare Regulatory Services Breakdown Data by Type
- 3.1 Global Life Sciences and Healthcare Regulatory Services Historic Market Size by Type (2021-2026)
- 3.2 Global Life Sciences and Healthcare Regulatory Services Forecasted Market Size by Type (2027-2032)
4 Life Sciences and Healthcare Regulatory Services Breakdown Data by Application
- 4.1 Global Life Sciences and Healthcare Regulatory Services Historic Market Size by Application (2021-2026)
- 4.2 Global Life Sciences and Healthcare Regulatory Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Life Sciences and Healthcare Regulatory Services Market Perspective (2021-2032)
- 5.2 Global Life Sciences and Healthcare Regulatory Services Growth Trends by Region
- 5.2.1 Global Life Sciences and Healthcare Regulatory Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Life Sciences and Healthcare Regulatory Services Historic Market Size by Region (2021-2026)
- 5.2.3 Life Sciences and Healthcare Regulatory Services Forecasted Market Size by Region (2027-2032)
- 5.3 Life Sciences and Healthcare Regulatory Services Market Dynamics
- 5.3.1 Life Sciences and Healthcare Regulatory Services Industry Trends
- 5.3.2 Life Sciences and Healthcare Regulatory Services Market Drivers
- 5.3.3 Life Sciences and Healthcare Regulatory Services Market Challenges
- 5.3.4 Life Sciences and Healthcare Regulatory Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Life Sciences and Healthcare Regulatory Services Players by Revenue
- 6.1.1 Global Top Life Sciences and Healthcare Regulatory Services Players by Revenue (2021-2026)
- 6.1.2 Global Life Sciences and Healthcare Regulatory Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Life Sciences and Healthcare Regulatory Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Life Sciences and Healthcare Regulatory Services Head Office and Area Served
- 6.4 Global Life Sciences and Healthcare Regulatory Services Players, Product Type & Application
- 6.5 Global Life Sciences and Healthcare Regulatory Services Manufacturers Established Date
- 6.6 Global Life Sciences and Healthcare Regulatory Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Life Sciences and Healthcare Regulatory Services Market Size (2021-2032)
- 7.2 North America Life Sciences and Healthcare Regulatory Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Life Sciences and Healthcare Regulatory Services Market Size by Country (2021-2026)
- 7.4 North America Life Sciences and Healthcare Regulatory Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Life Sciences and Healthcare Regulatory Services Market Size (2021-2032)
- 8.2 Europe Life Sciences and Healthcare Regulatory Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Life Sciences and Healthcare Regulatory Services Market Size by Country (2021-2026)
- 8.4 Europe Life Sciences and Healthcare Regulatory Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Life Sciences and Healthcare Regulatory Services Market Size (2021-2032)
- 9.2 Asia-Pacific Life Sciences and Healthcare Regulatory Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Life Sciences and Healthcare Regulatory Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Life Sciences and Healthcare Regulatory Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Life Sciences and Healthcare Regulatory Services Market Size (2021-2032)
- 10.2 South America Life Sciences and Healthcare Regulatory Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Life Sciences and Healthcare Regulatory Services Market Size by Country (2021-2026)
- 10.4 South America Life Sciences and Healthcare Regulatory Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Life Sciences and Healthcare Regulatory Services Market Size (2021-2032)
- 11.2 Middle East & Africa Life Sciences and Healthcare Regulatory Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Life Sciences and Healthcare Regulatory Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Life Sciences and Healthcare Regulatory Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Arnold & Porter
- 12.1.1 Arnold & Porter Company Information
- 12.1.2 Arnold & Porter Business Overview
- 12.1.3 Arnold & Porter Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.1.4 Arnold & Porter Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.1.5 Arnold & Porter Recent Developments
- 12.2 Baker McKenzie
- 12.2.1 Baker McKenzie Company Information
- 12.2.2 Baker McKenzie Business Overview
- 12.2.3 Baker McKenzie Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.2.4 Baker McKenzie Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.2.5 Baker McKenzie Recent Developments
- 12.3 Bird & Bird
- 12.3.1 Bird & Bird Company Information
- 12.3.2 Bird & Bird Business Overview
- 12.3.3 Bird & Bird Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.3.4 Bird & Bird Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.3.5 Bird & Bird Recent Developments
- 12.4 Celegence
- 12.4.1 Celegence Company Information
- 12.4.2 Celegence Business Overview
- 12.4.3 Celegence Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.4.4 Celegence Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.4.5 Celegence Recent Developments
- 12.5 Clarivate
- 12.5.1 Clarivate Company Information
- 12.5.2 Clarivate Business Overview
- 12.5.3 Clarivate Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.5.4 Clarivate Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.5.5 Clarivate Recent Developments
- 12.6 Cooley
- 12.6.1 Cooley Company Information
- 12.6.2 Cooley Business Overview
- 12.6.3 Cooley Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.6.4 Cooley Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.6.5 Cooley Recent Developments
- 12.7 Fenwick
- 12.7.1 Fenwick Company Information
- 12.7.2 Fenwick Business Overview
- 12.7.3 Fenwick Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.7.4 Fenwick Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.7.5 Fenwick Recent Developments
- 12.8 IQVIA
- 12.8.1 IQVIA Company Information
- 12.8.2 IQVIA Business Overview
- 12.8.3 IQVIA Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.8.4 IQVIA Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.8.5 IQVIA Recent Developments
- 12.9 Kirkland & Ellis LLP
- 12.9.1 Kirkland & Ellis LLP Company Information
- 12.9.2 Kirkland & Ellis LLP Business Overview
- 12.9.3 Kirkland & Ellis LLP Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.9.4 Kirkland & Ellis LLP Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.9.5 Kirkland & Ellis LLP Recent Developments
- 12.10 Larson Maddox
- 12.10.1 Larson Maddox Company Information
- 12.10.2 Larson Maddox Business Overview
- 12.10.3 Larson Maddox Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.10.4 Larson Maddox Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.10.5 Larson Maddox Recent Developments
- 12.11 Latham & Watkins LLP
- 12.11.1 Latham & Watkins LLP Company Information
- 12.11.2 Latham & Watkins LLP Business Overview
- 12.11.3 Latham & Watkins LLP Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.11.4 Latham & Watkins LLP Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.11.5 Latham & Watkins LLP Recent Developments
- 12.12 Norton Rose Fulbright
- 12.12.1 Norton Rose Fulbright Company Information
- 12.12.2 Norton Rose Fulbright Business Overview
- 12.12.3 Norton Rose Fulbright Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.12.4 Norton Rose Fulbright Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.12.5 Norton Rose Fulbright Recent Developments
- 12.13 Paul Hastings LLP
- 12.13.1 Paul Hastings LLP Company Information
- 12.13.2 Paul Hastings LLP Business Overview
- 12.13.3 Paul Hastings LLP Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.13.4 Paul Hastings LLP Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.13.5 Paul Hastings LLP Recent Developments
- 12.14 ProductLife Group
- 12.14.1 ProductLife Group Company Information
- 12.14.2 ProductLife Group Business Overview
- 12.14.3 ProductLife Group Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.14.4 ProductLife Group Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.14.5 ProductLife Group Recent Developments
- 12.15 PwC
- 12.15.1 PwC Company Information
- 12.15.2 PwC Business Overview
- 12.15.3 PwC Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.15.4 PwC Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.15.5 PwC Recent Developments
- 12.16 Ropes & Gray LLP
- 12.16.1 Ropes & Gray LLP Company Information
- 12.16.2 Ropes & Gray LLP Business Overview
- 12.16.3 Ropes & Gray LLP Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.16.4 Ropes & Gray LLP Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.16.5 Ropes & Gray LLP Recent Developments
- 12.17 Sidley Austin
- 12.17.1 Sidley Austin Company Information
- 12.17.2 Sidley Austin Business Overview
- 12.17.3 Sidley Austin Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.17.4 Sidley Austin Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.17.5 Sidley Austin Recent Developments
- 12.18 Simmons & Simmons
- 12.18.1 Simmons & Simmons Company Information
- 12.18.2 Simmons & Simmons Business Overview
- 12.18.3 Simmons & Simmons Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.18.4 Simmons & Simmons Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.18.5 Simmons & Simmons Recent Developments
- 12.19 Voisin Consulting Life Sciences
- 12.19.1 Voisin Consulting Life Sciences Company Information
- 12.19.2 Voisin Consulting Life Sciences Business Overview
- 12.19.3 Voisin Consulting Life Sciences Revenue in Life Sciences and Healthcare Regulatory Services Business (2021-2026)
- 12.19.4 Voisin Consulting Life Sciences Life Sciences and Healthcare Regulatory Services Product Portfolio
- 12.19.5 Voisin Consulting Life Sciences Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst